- Home
- BBGI vs IMRN Comparison
BBGI vs IMRN Comparison
Compare BBGI & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- IMRN
- Stock Information
- Founded
- BBGI 1961
- IMRN 1994
- Country
- BBGI United States
- IMRN Australia
- Employees
- BBGI N/A
- IMRN N/A
- Industry
- BBGI Broadcasting
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- IMRN Health Care
- Exchange
- BBGI Nasdaq
- IMRN Nasdaq
- Market Cap
- BBGI 8.1M
- IMRN 9.2M
- IPO Year
- BBGI 2000
- IMRN N/A
- Fundamental
- Price
- BBGI $4.12
- IMRN $1.75
- Analyst Decision
- BBGI
- IMRN Strong Buy
- Analyst Count
- BBGI 0
- IMRN 1
- Target Price
- BBGI N/A
- IMRN $5.00
- AVG Volume (30 Days)
- BBGI 134.4K
- IMRN 23.5K
- Earning Date
- BBGI 08-11-2025
- IMRN 09-08-2025
- Dividend Yield
- BBGI N/A
- IMRN N/A
- EPS Growth
- BBGI N/A
- IMRN N/A
- EPS
- BBGI N/A
- IMRN N/A
- Revenue
- BBGI $234,823,730.00
- IMRN $4,048,286.00
- Revenue This Year
- BBGI $5.02
- IMRN N/A
- Revenue Next Year
- BBGI N/A
- IMRN N/A
- P/E Ratio
- BBGI N/A
- IMRN N/A
- Revenue Growth
- BBGI N/A
- IMRN 82.90
- 52 Week Low
- BBGI $3.67
- IMRN $1.50
- 52 Week High
- BBGI $14.95
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- BBGI 43.43
- IMRN 49.16
- Support Level
- BBGI $3.80
- IMRN $1.67
- Resistance Level
- BBGI $4.52
- IMRN $1.78
- Average True Range (ATR)
- BBGI 0.34
- IMRN 0.10
- MACD
- BBGI 0.05
- IMRN -0.00
- Stochastic Oscillator
- BBGI 44.12
- IMRN 51.25
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.